Skip To Navigation Skip To Content Skip To Footer
    Advocacy Letter
    Home > Press Statements & Advocacy Letters > Advocacy Letters

    March 28, 2025 
     

    The Honorable Mark Green, MD The Honorable Kim Schrier, MD
    U.S. House of Representatives U.S. House of Representatives
    2446 Rayburn House Office Building 1110 Longworth House Office Building
    Washington, D.C. 20515 Washington, D.C. 20515

     

    The Honorable Gregory Murphy, MD
    U.S. House of Representatives
    407 Cannon House Office Building
    Washington, D.C. 20515


    Subject: Support for Reducing Medically Unnecessary Delays in Care Act (H.R. 2433)

    Dear Representatives Green, Murphy, and Schrier:

    On behalf of the undersigned members of the Regulatory Relief Coalition (RRC), a coalition of national physician organizations seeking to reduce regulatory burdens that interfere with patient care, we are pleased to support the Reducing Medically Unnecessary Delays in Care Act of 2025 (H.R. 2433). As a leading advocate for reforming prior authorization in the Medicare Advantage (MA) program on behalf of seniors and the physicians who care for them, the RRC applauds your leadership on this legislation to improve the prior authorization process in Medicare, MA, and Medicare Part D plans.

    The RRC greatly appreciates your commitment to ensuring that MA policies are not a barrier to timely and equitable access to care for the patients our members serve. We understand that your bill would reform prior authorization in Medicare, MA, and Part D by requiring that all prior authorizations and adverse determinations must be made by a licensed physician who is board certified in the specialty relevant to the health care item or service requested. It would also require plans to create policies based on medical necessity and written clinical criteria.

    RRC members agree that only qualified medical personnel — ideally providers of the same medical specialty or subspecialty as the prescribing/ordering physicians — should make these decisions. Furthermore, we agree that prior authorization decisions should reflect evidence-based guidelines consistent with national medical specialty society guidelines where available and applicable. As Congress considers legislation to reform prior authorization, we look forward to working with you to protect patients from unnecessary delays in care by enacting these prior authorization reforms into law.
     

    View the full letter


    More Advocacy Letters

    Ask MGMA
    An error has occurred. The page may no longer respond until reloaded. An unhandled exception has occurred. See browser dev tools for details. Reload 🗙